Renown Health First To Offer TomoTherapy Technology|
RENO, Nev. (Oct. 8, 2008) – Renown Institute for Cancer announced today a new piece of state-of-the-art equipment to treat a wide range of cancers. When installed in November, the new TomoTherapy Hi-Art® System will expand doctors’ ability to use therapeutic radiation to treat tumors with 3-D imaging and improved precision.
Only two percent of hospitals nation-wide have the technology including major cancer institutes like the Kimmel Cancer Center at Johns Hopkins, Baltimore, Md.; James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, N.Y.; City of Hope, Duarte, Calif.; MD Anderson Cancer Center Orlando, Orlando, Fla.; Cancer Center at Beth Israel Deaconess Medical Center, Boston, Mass. and University of Wisconsin Comprehensive Cancer Center, Madison, Wis.
Unlike traditional radiation therapy equipment, the Hi·Art® system utilizes an on-board computed tomography (CT) scanner. This allows true CT images of a patient’s anatomy to be created with the same equipment used to treat that patient. The system allows for tumors to receive their intended doses of radiation with minimal damage to surrounding healthy tissue, reducing patient side effects.
Patient Benefits of TomoTherapy compared to other radiation options:
Fewer side-effects because less healthy tissue impacted
Shorter and more accurate treatments
Most accurate radiation available due to CT scan capability
Ability to treat patients who have been told they could not receive any more therapy
Doctor Eric Rost, medical director of Radiation Oncology at Renown Institute for Cancer said this new system can deliver small beamlets of radiation from every point on a spiral, which provides for exceptional accuracy.
“TomoTherapy is not only an evolutionary advancement in radiation delivery, but it also is a revolutionary change in the treatment of all cancers,” Rost said. “Clinical outcomes for patients are also significantly better than other radiation treatment options with much less side effects.”
Dr. Rost previously presided over one of the first installations of a TomoTherapy Hi-Art® System and has brought his expertise to Renown Health. As a consultant, he was involved with the building of 10 TomoTherapy programs world-wide including Arizona, England, Florida, Italy, Korea and Spain.
He also said the Hi-Art® System has applications for an assortment of cancer treatments across many disciplines treating cancers throughout the entire body. More specifically, mesothelioma, an asbestos-related cancer of the lining of the lung or the lining of the abdominal cavity, can only be treated with TomoTherapy.
TomoTherapy can treat all solid tumors, he said. However, it is especially good at treating tumors of the brain and spinal cord and patients who are told they have already had radiation and cannot have anymore. Other treatment applications include skin, lung, GYN (ovarian, cervix, endometrium), breast, bone, head and neck, prostate, pediatric, liver, colon, anal, lymphoma, esophagus, gastric and pancreatic cancers.
How the TomoTherapy Hi·Art® treatment system works:
Before each treatment, the patient, lying on the bed, moves through the Hi-Art® machine for a CT scan, called a CTrue image. Images taken verify the shape, size and location of the tumor as well as all critical structures.
The CTrue image is compared to the original planning CT image (which may have been taken days before). If necessary, adjustments to the plan and patient set-up are made immediately.
The patient then moves through the Hi·Art® treatment system again where radiation is delivered in tens of thousands of beamlets in a helical pattern (360°) around the tumor. Each procedure takes approximately 15 minutes.
“We are constantly looking at cancer treatment options,” said Linda Ferris, Ph.D., vice president of Renown Institute for Cancer. “We added da Vinci last February and TomoTherapy is another amazing new machine in Renown Institute for Cancer’s toolbox to treat cancer. There are other tools out there, but we’ve concluded that this technology is different and unique, essentially a step above the rest.”
Renown Institute for Cancer has been the region’s first hospital recognized by the American College of Surgeons Commission on Cancer for comprehensive cancer care for more than 20 years. Only 25 percent of hospitals nationwide meet the Commission’s rigorous standards.
In February 2008, Renown Health was the region’s first hospital to introduce the da Vinci® S HD™ Robotic Surgical System, a system that applies a surgeon’s skill to computer-enhanced technology and robotics. By enhancing surgical capabilities, the da Vinci surgical system helps to improve clinical outcomes for patients across many disciplines including various heart and cancer procedures. A number of procedures like the heart valve repair and prostatectomy that previously could not be performed using traditional minimally invasive surgery technologies have been performed at Renown using the da Vinci surgical system.
Renown Health is also the largest hospital in the area conducting clinical trials with the National Cancer Institute. Clinical trials allow patients to be on leading trends in medicine and often times they become involved in that "next big discovery" for cancer treatments.
About TomoTherapy Incorporated
TomoTherapy Incorporated has developed, manufactures and sells the Hi·Art® system, one of the most advanced and versatile radiation therapy systems commercially available for the treatment of a wide variety of cancers.
TomoTherapy Incorporated markets the Hi·Art® treatment system to university research centers, hospitals, private and governmental institutions and cancer treatment centers in North America, Europe and Asia.